Heritage launches its formulation of the generic hydrochlorothiazide

EDISON, N.J. Heritage Pharmaceuticals has launched its new drug hydrochlorothiazide.

The drug is used as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. The drug is also used in the management of hypertension.

The drug is available in 25 and 50 mg tablets in 100 and 1000 count bottles. Total annual market sales for Hydrochlorothiazide tablets in the U.S. were $30.8 million, according to March 2007 IMS data.